LivingGLP1
Study S002044

A Single-Arm, Open-Label, Pre-Post Controlled Clinical Study to Evaluate the Effect of Mazdutide on Annualized Flare Rate in Adults With Obesity and Gout

Registration

Registration
NCT07824895
Study type
INTERVENTIONAL
Phase
PHASE4
Masking
NONE
Status
NOT_YET_RECRUITING
Enrollment
30
Start
2026-09-15
Primary completion
2027-12-31
Lead sponsor
Hongwei Jiang
Conditions
Gout; Obesity (BMI>30); Hyperuricemia; Metabolic Syndrome
Interventions
DRUG:Mazdutide
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Annualized Flare Rate (AFR) [Baseline to Week 52;Unit of Measure: Flares per person-year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.